Here are three things to know.
- The 12.5 milligram dose of the medication is being pulled off the market over failed dissolution specifications.
- Paroxetine is used to treat patients with depression, panic disorder and social anxiety disorder.
- The Food and Drug Administration labeled the recall as a Class III event, meaning the quality issue is not likely to cause adverse health risks to patients.
More articles on supply chain:
Herbal coffee recalled for containing erectile dysfunction drug ingredien
Puma Biotech earns FDA approval for breast cancer drug
A supply chain expert on what your performance dashboard is missing
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
